Table 3.
Comparison of the laboratory results in the non-recurrence and recurrence groups.
| Parameter (No. of Patients in NRG vs. RG) | Non- Recurrence Group (NRG) | Recurrence Group (RG) | p Value | Reference Range and Unit | ||
|---|---|---|---|---|---|---|
| Mean ± SD | Abnormal (%)* | Mean ± SD | Abnormal (%)* | |||
| TSH (40 vs. 9) | 0.101 ± 0.232 | 89.8 | 0.646 ± 0.773 | 44.4 | 0.015 | 0.27–4.2 mIU/L |
| FT4 (39 vs. 9) | 3.029 ± 1.604 | 84.6 | 1.79 ± 0.628 | 44.4 | 0.006 | 0.93–1.7 ng/dL |
| FT3 (39 vs. 9) | 7.237 ± 3.88 | 69.2 | 4.332 ± 1.189 | 44.4 | 0.025 | 2.6–4.4 pg/mL |
| aTPO (37 vs. 8) | 36.54 ± 63.3 | 18.9 | 12.773 ± 3.349 | 0.0 | 0.029 | <34 IU/mL |
| aTg (36 vs. 8) | 140.5 ± 203 | 27.8 | 96.9 ± 133 | 25 | 0.394 | <115 IU/mL |
| TRAb (32 vs. 7) | 1.84 ± 6.99 | 6.25 | 1.207 ± 1.851 | 14.3 | 0.726 | <1.75 IU/mL |
| ESR (38 vs. 9) | 66.6 ± 20 | 100 | 59.4 ± 21.5 | 100 | 0.381 | 0-12 mm/h |
| CRP (36 vs. 9) | 9.85 ± 12.3 | 100 | 5.08 ± 4.66 | 100 | 0.156 | <1 mg/dL |
| WBC (39 vs. 9) | 8.938 ± 3.105 | 25.6 | 9.894 ± 3.599 | 44.4 | 0.322 | 4.0–10.0 × 103/µL |
| 25-hydroxy vitamin D (27 vs. 9) | 22.8 ± 8.356 | 74 | 23.9 ± 7.873 | 66.7 | 0.736 | 30-50 ng/mL |
* Below the reference range in the case of TSH and 25-hydroxy vitamin D, above the reference range in the cases of all other parameters. A p-value of <0.05 is considered statistically significant. P-values <0.05 are marked in bold. Data are presented as: mean and standard deviation (SD). Abbreviations: aTg, anti-thyroglobulin antibodies; aTPO, anti-thyroid peroxidase antibodies; CRP, C reactive protein; ESR, erythrocyte sedimentation rate; FT3, free triiodothyronine; FT4, free thyroxine; TRAb, TSH receptor antibodies; TSH, thyrotropin; WBC, white blood cells.